Latest News

Long-Term Survival Benefit Associated with CRT-D Compared to ICD in HF in the RAFT Trial
Written by: Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
Long-Term Survival Benefit Associated with CRT-D Compared to ICD in HF in the RAFT Trial
Findings from an Apolipoprotein B-Based Genetic Analysis
Written by: Radcliffe Cardiology, Greg Guillory
New Study Finds Lipoprotein(a) More Atherogenic Compared to LDL
American College of Cardiology Reveals its Late-Breaking Clinical Trial Presentations for 2024
Written by: ACC.24, Radcliffe Cardiology
American College of Cardiology Reveals its Late-Breaking Clinical Trial Presentations for 2024
Apixaban Reduces Stroke Risk in Subclinical Atrial Fibrillation compared to Aspirin at the cost of Increased bleeding
Written by: Radcliffe Cardiology, Mirjam Boros; Special Editor: Greg Guillory
Apixaban Reduces Stroke Risk in Subclinical Atrial Fibrillation Compared to Aspirin at the Cost of Increased…
Encouraging Top Line Results from ARISE-HF Phase III Study of AT-001 in Diabetic Cardiomyopathy
Written by: Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
Encouraging Top Line Results from ARISE-HF Phase III Study of AT-001 in Diabetic Cardiomyopathy
Written by: AF Symposium, Jordan Rance
The 29th Annual AF Symposium reveals its Late-Breaking Clinical Trial Presentations for 2024
Dietary Modifications on Sodium Intake and The Impact on Blood Pressure
Written by: CardioNerds for Radcliffe Cardiology
Dietary Modifications on Sodium Intake and The Impact on Blood Pressure
Promising Breakthroughs in Lowering Lipoprotein(a) Levels with Lepodisiran: A Beacon of Hope for Patients with elevated Lipoprotein(a)
Written by: CardioNerds for Radcliffe Cardiology
Promising Breakthroughs in Lowering Lipoprotein(a) Levels with Lepodisiran: A Beacon of Hope for Patients…
AHA 2023 Late-Breaking Science Lineup Revealed
Written by: AHA, Jordan Rance
AHA 2023 Late-Breaking Science Lineup Revealed
TCT 23: Late-Breaking Clinical Trials Revealed
Written by: Radcliffe Cardiology
TCT 23: Late-Breaking Clinical Trials Revealed

External news

Written by: Medscape
Risk Score Predicts GI Bleeding Among Post-PCI Patients
Written by: Medscape
Goodbye CHADSVASc: Sex Complicates Stroke Risk Scoring in AF
Written by: Cardiovascular Business
Cardiologist receives 35 months in prison for health insurance fraud
Written by: Cardiovascular Business
No-contact blood pressure and diabetes screening with AI shows promise
Written by: Cardiovascular Business
Self-expanding vs. balloon-expandable TAVR valves: How they compare after 5 years
Written by: Medscape
Pre-op Evaluations: Does This Patient Really Need One?
Written by: Medscape
Private Equity: Medicine’s Professional Groups Must Weigh In
Written by: Medscape
Mitral Regurgitation in HF: Optimizing Outcomes
Written by: Cardiac Vascular News
At RSNA 2024, Agfa Radiology Solutions’ in-booth presentations empower X-ray experts with insights and innovations
Written by: Cardiac Vascular News
RADPAIR Named “Best New Radiology Vendor 2024” at AuntMinnie.com’s Minnies Awards